Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Revenio Group OyjSTU:R0V -7.03%78 Interest Coverage is 8.00 as of Jun. 2026, which is 91% below its 10-year median of 89.32. GuruFocus rates STU:R0V with a GF Score™ of 78/100 and a GF Value™ of €38.32 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 461 Medical Devices & Instruments companies, Revenio Group Oyj ranks worse than 56.18% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Revenio Group Oyj's
Operating Income
for the
three
months ended in Jun. 2026 was €2.4 Mil. Revenio Group Oyj's Interest Expense for the
three
months ended in Jun. 2026 was €-0.3 Mil.
Revenio Group Oyj's interest coverage for the quarter that ended in Jun. 2026 was 8.00.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Revenio Group Oyj's Interest Coverage or its related term are showing as below:
STU:R0V'
s Interest Coverage Range Over the Past 10 Years
Min: 36.33 Med: 89.32 Max: 2707.67
Current: 58.33
STU:R0V's Interest Coverage is ranked worse than 56.18% of 461
companies
in the Medical Devices & Instruments industry
Industry Median: 16.6
vs STU:R0V: 58.33
Revenio Group Oyj (STU:R0V) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Revenio Group Oyj Interest Coverage Related Terms
Revenio Group Oyj Interest Coverage Historical Data
* Premium members only.
The historical data trend for Revenio Group Oyj's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
STU:R0V vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Revenio Group Oyj's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revenio Group Oyj Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Revenio Group Oyj's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revenio Group Oyj (STU:R0V) has a Interest Coverage of 8.00 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Revenio Group Oyj and its competitors. This is 91% below median its historical median of 89.32. Over the past decade, Revenio Group Oyj's Interest Coverage has ranged from 36.33 to 2,707.67. According to the industry distribution chart, Revenio Group Oyj ranks #259 out of 461 companies in the Medical Devices & Instruments industry, placing it in the top 56.2%.
Is Revenio Group Oyj's Interest Coverage too high?
Revenio Group Oyj's current Interest Coverage of 8.00 is 91% below median its 10-year median of 89.32. Over the past 10 years, this metric has ranged from a low of 36.33 to a high of 2,707.67. The Medical Devices & Instruments industry median Interest Coverage is 16.60. Revenio Group Oyj's value of 8.00 is 51.8% below this industry median. Based on the distribution chart, Revenio Group Oyj ranks #259 out of 461 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Revenio Group Oyj has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Revenio Group Oyj ranks #259 out of 461 companies for Interest Coverage. This places Revenio Group Oyj in the lower half of its industry. The industry median Interest Coverage is 16.60. Revenio Group Oyj's value of 8.00 is 51.8% below this benchmark. Historically, Revenio Group Oyj's own Interest Coverage has ranged from 36.33 to 2,707.67 over the past decade. While the company's 10-year median is 89.32 vs. the industry median of 16.60, Revenio Group Oyj has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.60, based on 461 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Revenio Group Oyj's current Interest Coverage of 8.00 is 51.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Revenio Group Oyj and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revenio Group Oyj's current Interest Coverage is 8.00, which is 91% below median its own 10-year median of 89.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Based on GuruFocus' analysis, Revenio Group Oyj (STU:R0V) is currently considered Significantly Undervalued. The stock's GF Value™ is €38.32, compared to a current price of €14.02 — trading 63.4% below its estimated fair value. The current Interest Coverage is 8.00, which is 91% below median its 10-year median of 89.32 and 51.8% below the Medical Devices & Instruments industry median of 16.60. Revenio Group Oyj's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Revenio Group Oyj (STU:R0V), the current Interest Coverage is 8.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Revenio Group Oyj (STU:R0V) Overvalued in 2026?
Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued.
The current stock price of €14.02 is trading 63.4% below its estimated GF Value™ of €38.32.
GuruFocus considers Revenio Group Oyj to be Significantly Undervalued.
Key valuation signals for STU:R0V:
Interest Coverage: 8.00 (91% below median its 10-year median of 89.32)
GF Value™: €38.32 vs. price of €14.02 (63.4% below fair value)
Industry Position: 51.8% below the Medical Devices & Instruments median (#259 of 461)
No single metric tells the full story. See the STU:R0V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
78GF Score
Get the complete analysis for STU:R0V
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:R0V has been successfully added to your 
